Bo Mi SEO
변호사
T. 02-3477-8695
F. 02-3477-0782
E. bmseo@law-lin.com
Overview
Case Highlights
Profile
Related News
Attorney Seo Bomi is a partner attorney at law firm LIN. Since she started her career in the financial sector in 2009, she has accumulated diverse work experience and expertise in corporate advisory, including domestic and international M&A and Post-Merger Integration, domestic and international investment advisory, finance, and joint ventures, while working as an in-house counsel for domestic and international large corporations and financial companies, and as a law firm attorney.
Additionally, she actively provides advisory services in the TMT sector, covering fintech, personal information protection, IT, and compliance, as well as in the medical and healthcare sectors.
Additionally, she actively provides advisory services in the TMT sector, covering fintech, personal information protection, IT, and compliance, as well as in the medical and healthcare sectors.
Profile
Experience
- Committee Member, Medical Device Advertising Deliberation Committee, Korea Medical Device Industry Association (Current)
- Advisory Member, Private Advertising Verification Group, Ministry of Food and Drug Safety (Current)
- [Public Service]
- Europe/Oceania Subcommittee Member, Seoul Bar Association (Former)
- International Committee Member, Seoul Bar Association (Former)
- Women Lawyers Special Committee Member, Korean Bar Association (Former)
- Full Member, Financial Technology Law Research Group (Current)
- Full Member, Financial Lawyers Association of the Korean Bar Association (Current)
- Public Relations Committee Member, Seoul Bar Association (Current)
- Planning Committee Member, Korean Bar Association (Current)
- [Academic Societies and Committees]
- LIN LLC Attorney (Current)
- Chanel Korea Ltd. Seconded Attorney (Former)
- Shin & Partners Law Office Attorney (Former)
- DL Chemical (formerly Daelim Industrial) In-house Counsel (Former)
- Fink Co., Ltd. In-house Counsel (Former)
- Synergy Partners/IB Investment In-house Counsel (Former)
- Law Firm Seum Attorney (Former)
- PCA Life Insurance In-house Counsel (Former)
- Korea Housing Finance Corporation (Former)
- Shinhan Investment Corp. (Former)
- [Major Experience]
Representative Matters
•Advisory for F, operator of the domestic social activity platform R, on strategic investment attraction from Y.
•Advisory for the Japanese corporation A, which provides the hotel and flight booking service platform S, and its Korean subsidiary K.
•Advisory for listed company D's acquisition of US listed companies C and K.
•Advisory for the acquisition of listed paper/packaging material manufacturing and real estate development companies.
•Advisory for I's equity acquisition of a cosmetics company.
•Advisory for K's acquisition of a music content company and an online book publishing/distribution company.
•Advisory for K Securities and New Technology Investment Association's investment in a broadcasting content company.
•Advisory for stalking horse acquisition of a company under rehabilitation.
•Advisory for PEF's investment in an LED manufacturer.
•Advisory for U's acquisition of a medicine packaging material manufacturer.
•Advisory for listed company H's acquisition of an autonomous driving and car wash service company.
•Advisory for PEF's investment in a ventilation and dehumidification company.
•Due diligence for K Construction's real estate acquisition.
•Due diligence for listed company G's waste treatment company.
•Advisory for listed company H's acquisition of a US food and health company.
•Advisory for mergers between limited liability companies.
•Advisory for listed company P's investment in a secondary battery company.
•Advisory for small-scale and simplified mergers between companies.
•Advisory for a domestic company's equity acquisition of a US startup.
•Advisory for Simple Agreement for Future Equity (SAFE).
•Advisory for foreign exchange transaction reporting.
•Post-Merger Integration (PMI) advisory - including HR/labor management, consolidation/merger between affiliated companies, asset transfer, personal information transfer, fair trade law reporting and disclosure advisory, IT integrated system establishment for overseas affiliated companies (Singapore, USA, Brazil, Belgium, Japan), real estate lease, logistics, and employment contract advisory.
•Advisory for overseas technology license agreements.
•Defense against trademark infringement claims and advisory for trademark license agreements.
•Advisory on investment eligibility of overseas corporations.
•Accelerator advisory related to attracting strategic investors such as companies A, F, and L.
•Advisory for disputes between co-founders and disputes between major shareholders and investors.
•Advisory for shareholder proposals.
•Advisory related to regular and special inspections by the Financial Supervisory Service and defense against sanctions.
•Advisory related to innovative financial services and financial regulatory sandbox.
•Advisory related to corporate spin-offs.
•Advisory related to requirements for substantive delisting review.
•Fair trade advisory related to personnel exchange and financial support between affiliated companies.
•Advisory and services for rehabilitation claim filing.
•M&A and domestic/international investment advisory for domestic investment companies and new technology financial companies.
•Advisory for joint venture establishment and operation.
•Advisory for establishment of startup investment companies and startup investment associations.
•Advisory for US private equity firm's acquisition of redeemable convertible preferred stock in domestic venture companies.
•Advisory for CB and BW issuance.
•Advisory related to domestic and international corporate establishment and corporate governance.
•Advisory on financial regulations, personal information protection, IT, and compliance.
•Advisory on insurance, fintech, and healthcare.
•Advisory on blockchain and ICO matters.
•Advisory related to medical law for diagnostic kit companies.
•Advisory related to rehabilitation and bankruptcy matters for medical institutions.
•Advisory for acquisition of pharmaceutical and bio companies.
Education
•Chung-Ang University High School Attached (2004)
•Korea University, Education/Economics (Summa Cum Laude, 2009)
•Korea University School of Law (2015)
•University of Queensland (EAP Completion)
•Harvard Medical School (Digital Transformation in Healthcare Executive Completion)
•Seoul National University School of Law, Financial Law Program 15th Class (Completion of Theory and Practice of Compliance)
•Bar Examination (4th)
Qualifications
•Attorney at Law
Languages
•Korean
•English